Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion

Neurobiology of Disease

Volumn 5, Issue 6, 1998, Pages 432-446

  Murphy, Laura L ^a   Muñoz, Raúl M ^b   Adrian, Brian A ^a   Villanúa, María A ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

ACTH; Cannabinoid receptors; Cannabinoids; Glucocorticoids; Growth hormone; Hormone secretion; LH; Neuroendocrine system; Prolactin; Sex steroids; Thyroid hormones

Indexed keywords

4 AMINOBUTYRIC ACID; ADENOHYPOPHYSIS HORMONE; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; CORTICOSTERONE; CORTICOTROPIN; DOPAMINE; DRONABINOL; GLUTAMIC ACID; GONADORELIN; GONADOTROPIN; GROWTH HORMONE; NORADRENALIN; PROLACTIN; TESTOSTERONE; THYROTROPIN;

ADENOHYPOPHYSIS; ARTICLE; CANNABIS ADDICTION; GENITAL SYSTEM; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LACTATION; METABOLISM; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; STRESS;

EID: 0344938184     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1998.0224     Document Type: Article

References (126)

1. Mechoulam R. Marihuana chemistry. Science. 168:1970;1159-1166.
2. Devane W. A., Dysarz F. A. III, Johnson M. R., Melvin L. S., Howlett A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:1988;605-613.
3. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
4. Fride E., Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:1993;313-314.
5. Crawley J. N., Corwin R. L., Robinson J. K., Felder C. C., Devane W. A., Axelrod J. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46:1993;967-972.
6. Smith P. B., Compton D. R., Welch S. P., Razdan R. K., Mechoulam R., Martin B. R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270:1994;219-227.
7. Besch N. R., Smith C. G., Besch P. K., Kaufman R. H. The effect of marihuana (delta-9-tetrahydrocannabinol) on the secretion of luteinizing hormone in the ovariectomized rhesus monkey. Am. J. Obstet. Gynecol. 128:1977;635-642.
8. 9. Life Sci. 27:1980;1911-1916.
9. Murphy L. L., Steger R. W., Smith M. S., Bartke A. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and i ncombinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology. 52:1990;316-321.
10. 9. Substance Alcohol Actions Misuse. 4:1983;339-345.
11. Murphy L. L., Chandrashekar V., Bartke A. Delta-9-tetrahydrocannabinol inhibits pulsatile luteinizing hormone secretion in the male rat. Effect of intracerebroventricular norepinephrine infuxion. Neuroendocrinol. Lett. 16:1994;1-7.
12. 1. Nature. 243:1973;470-471.
13. 1. Neuroendocrinology. 23:1977;31-42.
14. 1. Prog. Brain Res. 39:1973;331-338.
15. Tyrey L. Δ-9-Tetrahydrocannabinol suppression of episodic luteinizing hormone secretion in the ovariectomized rat. Endocrinology. 102:1978;1808-1814.
16. Sarkar D. K., Fink G. Luteinizing hormone releasing factor in pituitary stalk plasma from long-term ovariectomized rats: Effects of steroids. J. Endocrinol. 86:1980;511-524.
17. Carmel P. W., Araki S., Ferin M. Pituitary stalk portal blood collection in rhesus monkeys: Evidence for pulsatile release of gonadotropin-releasing homone (GnRH). Endocrinology. 99:1976;243-248.
18. 9. J. Pharmacol. Exp. Ther. 213:1980;306-308.
19. Smith C. G., Besch N. F., Smith R. G., Besch P. K. Effect of tetrahydrocannabinol on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey. Fertil. Steril. 31:1979;335-339.
20. 9. Fertil. Steril. 35:1981;567-572.
21. Wenger T., Rettori V., Snyder G. D., Dalterio S., McCann S. M. Effects of delta-9-tetrahydrocannabinol on the hypothalamic-pituitary control of luteinizing hormone and follicle-stimulating hormone secretion in adult male rats. Neuroendocrinology. 46:1987;488-493.
22. Chakravarty I., Shah P. G., Sheth A. R., Ghosh J. J. Mode of action of delta-9-tetrahydrocannabinol on hypothalamo-pituitary function in adult female rats. J. Reprod. Fertil. 57:1979;113-115.
23. 9. Neuroendocrinology. 37:1983;361-370.
24. 9. Fertil. Steril. 31:1979;331-334.
25. 9Macaca mulatta. J. Clin. Endocrinol. Metab. 52:1981;50-55.
26. 9. Fertil. Steril. 32:1979;576-582.
27. Smith C. G., Almirez R. G., Scher P. M., Asch R. H. Tolerance to the reproductive effects of delta-9-tetrahydrocannabinol: Comparison of the acute, short-term, and chronic drug effects on menstrual cycle hormones. The Cannabinoids: Chemical, Pharmacologic, and Therapeutic Aspects. 1984;Academic Press, San Diego. p. 471-485.
28. 9. Science. 219:1983;1453-1455.
29. Block R. I., Farinpour R., Schlechte J. A. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle-stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. 28:1991;121-128.
30. Bauman J. E. Marijuana and the female reproductive system. Health Consequences of Marijuana Use. 1980;U.S. Government Printing Office, Washington. p. 85-97.
31. Mendelson J. H., Mello N. K. Effects of marijuana on neuroendocrine hormones in human males and females. Braude M. C., Ludford J. P. Marijuana Effects on the Endocrine and Reproductive Systems. 1984;97-109 U.S. Government Printing Office, Washington.
32. Mendelson J. H., Mello N. K., Ellingboe J., Skupny A. S. T., Lex B. W., Griffin M. Marihuana smoking suppresses luteinizing hormone in women. J. Pharmacol. Exp. Ther. 237:1986;862-866.
33. Mendelson J. H., Cristofaro P., Ellingboe J., Benedikt R., Mello N. K. Acute effects of marihuana on luteinizing hormone in menopausal women. Pharmacol. Biochem. Behav. 23:1985;765-768.
34. Rodríguez de Fonseca F., Cebeira M., Ramos J. A., Martin M., Fernández-Ruiz J. J. Cannabinoid receptors in rat brain areas: Sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci. 54:1994;159-170.
35. Chakravarty I., Sheth P. R., Sheth A. R., Ghosh J. J. Delta-9-tetrahydrocannabinol: its effects on the hypothalamo-pituitary system in male rats. Arch. Androl. 8:1982;25-27.
36. 9. Pharmacol. Biochem. Behav. 8:1978;673-678.
37. Harclerode J., Nyquist S. E., Nagar B., Lowe D. Effect of cannabis on sex hormones and testicular enzymes of the rodent. Nahas G. G., Paton W. D. M. Marihuana: Biological Effects. 1979;395-405 Pergamon Press, Oxford.
38. 9. Pharmacol. Biochem. Behav. 48:1994;1011-1017.
39. Steger R. W., Murphy L. L., Bartke A., Smith M. S. Effects of psychoactive and nonpsychoactive cannabinoids on the hypothalamic-pituitary axis of the adult male rat. Pharmacol. Biochem. Behav. 37:1990;299-302.
40. Smith C. G., Moore C. E., Besch N. F., Besch P. K. The effect of marihuana (delta-9-tetrahydrocannabinol) on the secretion of sex hormones in the mature male rhesus monkey. Clin. Chem. 22:1976;1184.
41. Mendelson J. H., Kuehnle J., Ellingboe J., Barbor J. F. Plasma testosterone levels before, during and after chronic marijuana smoking. N. Engl. J. Med. 291:1974;1051-1055.
42. Mendelson J. H., Ellingboe J., Kuehnle J. C., Mello N. K. Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J. Pharmacol. Exp. Ther. 207:1978;611-617.
43. Dax E. M., Pilotte N. S., Adler W. H., Nagel J. E., Lange W. R. The effects of 9-ene-tetrahydrocannabinol on hormone release and immune function. J. Steroid Biochem. 34:1989;263-270.
44. Kolodny R. C., Masters W. H., Kolodny R. M., Toro G. Depression of plasma testosterone levels after chronic intensive marijuana use. N. Engl. J. Med. 290:1974;872-874.
45. Cone E. J., Johnson R. E., Moore J. D., Roache J. D. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol. Biochem. Behav. 24:1986;1749-1754.
46. Kolodny, R. C. Lessin, R. C. Toro, G. Masters, W. H. Cohen, S. 1976, Depression of plasma testosterone with acute marihuana administration, The Pharmacology of Marijuana, M. C. BraudeS. Szara, 217, 225, Raven Press, New York.
47. 2. Res. Commun. Subst. Abuse. 1:1980;407-426.
48. Tyrey L. Delta-9-tetrahydrocannabinol attenuates luteinizing hormone release induced by electrochemical stimulation of the medial preoptic area. Biol. Reprod. 47:1992;262-267.
49. Murphy L. L., Tyrey L. Induction of luteinizing hormone release by electrochemical stimulation of the medial preoptic area in delta-9-tetrahydrocannabinol-blocked proestrous rats. Neuroendocrinology. 43:1986;471-475.
50. 9. Subst. Alcohol Actions/Misuse. 4:1983;37-43.
51. 2. Proc. Natl. Acad. Sci. USA. 87:1990;10063-10066.
52. 9. Pharmacol. Biochem. Behav. 26:1987;533-537.
53. Murphy L. L., Steger R. W., Bartke A. Psychoactive and non-psychoactive cannabinoids and their effects on reproductive neuroendocrine parameters. Watson R. R. Biochemistry and Physiology of Subtance Abuse. 1990;73-93 CRC Press, Boca Raton.
54. Poddar M. K., Dewey W. L. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes. J. Pharmacol. Exp. Ther. 214:1980;63-67.
55. Shen M., Piser T. M., Seybold V. S., Thayer S. A. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16:1996;4322-4334.
56. Rodríguez de Fonseca F., Fernández-Ruiz J. J., Murphy L. L., Cebeira M., Steger R. W., Bartke A., Ramos J. A. Acute effects of Δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacol. Biochem. Behav. 42:1992;269-275.
57. Sakurai-Yamashita Y., Kataoka Y., Fujiwara M., Mine K., Showa U. Delta-9-tetrahydrocannabinol facilitates striatal dopaminergic transmission. Pharmacol. Biochem. Behav. 33:1989;397-400.
58. Chen J., Paredes W., Li J., Smith D., Lowinson J., Gardner E. L. Delta-9-tetrahydrocannabinol produces naloxone blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology. 102:1990;156-162.
59. 9. Neuropharmacology. 27:1988;1256-1270.
60. Pertwee R. G. The central neuropharmacology of cannabinoids. Pharmacol. Ther. 36:1988;189-261.
61. 9. Subst. Alcohol Actions/Minuse. 5:1984;201-210.
62. Weidenfeld J., Feldman S., Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor antagonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology. 59:1994;110-112.
63. Jackson A. L., Murphy L. L. Role of the hypothalamic-pituitary-adrenal axis in the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol. Neuroendocrinology. 65:1997;446-452.
64. 9. Neuroendocrinol. Lett. 14:1992;349-355.
65. Keller P., Kohli M., Murphy L. L. Naloxone reverses but does not prevent delta-9-tetrahydrocannabinol-induced inhibition of pulsatile LH secretion in ovariectomized rats. Soc. Neurosci. Abstracts. 16:1990;1101.
66. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., deCosta B. R., Rice K. C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J. Neurosci. 11:1990;563-583.
67. 1. Biochem. Pharmacol. 53:1997;1919-1927.
68. Matsuda L. A., Bonner T. I., Lolait S. J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327:1993;535-550.
69. Childers S. The anatomical distribution of brain cannabinoids receptors. Neurobiol. Dis. 5:1998;417-431.
70. Statham B. C., Bartke A., Murphy L. L. Evidence that cannabinoid receptors mediate the suppression of luteinizing hormone release by delta-9-tetrahydrocannabinol in ovariectomized rats. Soc. Neurosci. Abstracts. 21:1995;726.
71. Murphy L. L., Statham B. C. The role of cannabinoid receptors in the luteinizing hormone (LH) and adrenocorticotropin (ACTH) response to cannabinoids. Soc. Neurosci. Abstr. 22:1996;1344.
72. Martín-Calderón J. L., Muñoz R. M., Villanúa M. A., del Arco I., Moreno J. L., Rodríguez de Fonseca F., Navarro M. Characterization of the acute endocrine actions of HU-210, a potent synthetic cannabinoid in rats. Eur. J. Pharmacol. 1998.
73. Murphy L. L. The effect of anandamide and methanandamide on luteinizing hormone (LH), adrenocorticotropin (ACTH), and corticosterone (CORT) release in female rats. Soc. Neurosci. Abstr. 23:1997;2049.
74. Wenger T., Tóth B. E., Martin B. R. Effects of anandamide (endogenous cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. Life Sci. 56:1995;2057-2063.
75. Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
76. Gérard C. M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279:1991;129-134.
77. Adashi E. Y., Jones P. B. C., Hsueh A. J. W. Direct antigonadal activity of cannabinoids: Suppression of rat granulosa cell functions. Am. J. Physiol. 244:1983;E177-E185.
78. Burstein S., Hunter S. A., Shoupe T. S., Taylor P., Bartke A., Dalterio S. Cannabinoid inhibition of testosterone synthesis by mouse Leydig cells. Res. Commu. Chem. Pathol. Pharmacol. 19:1978;557-561.
79. Hembree W. C., Zeidenberg P. III, Nahas G. G. Marijuana effects on human gonadal function. Nahas G. G. Marihuana: Chemistry, Biochemistry, and Cellular Effects. 1976;521-532 Springer-Verlag, New York.
80. Bloch E., Thysen B., Morrill G. A., Gardner E., Fujimoto G. Effect of cannabinoids on reproduction and development. Vitam. Horm. 36:1978;203-258.
81. 1. Exp. Brain Res. 46:1982;85-88.
82. 9. Neuroendocrinology (Life Sci. Adv.). 11:1992;147-156.
83. 9. Eur. J. Pharmacol. 12:1970;382-384.
84. 9. Life Sci. 15:1974;329-338.
85. 3. Eur. J. Pharmacol. 47:1978;303-310.
86. Rodríguez de Fonseca F., Fernández-Ruiz J. J., Murphy L. L., Eldridge J. C., Steger R. W., Bartke A. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments. Pharmacol. Biochem. Behav. 40:1991;593-598.
87. Kubena R. K., Perhack J. C., Barry H. Corticosterone elevation mediated centrally by delta-1-tetrahydrocannabinol in rats. Eur. J. Pharmacol. 14:1971;89-94.
88. Maskarinec M. P., Shipley G., Novotny M., Brown D. J., Fozney R. B. Endocrine effects of cannabis in male rats. Toxicol. Appl. Pharmacol. 45:1978;615-628.
89. 9. Life Sci. 18:1976;223-230.
90. Neto J. P., Nunes J. F., Carvalho F. V. The effects of chronic cannabis treatment upon brain 5-hydroxytryptamine, plasma corticosterone and aggressive behavior in female rats with different hormonal status. Psychopharmacology. 42:1975;195-200.
91. 9. J. Pharm. Pharmacol. 31:1979;341-342.
92. Bailey J. R., Paule M. G., Ali S. F., Scallet A. C., Slikker W. Chronic marijuana smoke exposure in the rhesus monkey II: Effects on urinary cortisol, plasma cortisol and plasma testosterone concentrations. Int. Cannab. Res. Soc. Ann. Mtg. Abstr. 5:1990;12.
93. 9. Soc. Neurosci. Abstr. 22:1996;166.
94. Pertwee R. G. Tolerance to the effect of delta-1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta-1-tetrahydrocannabinol. Br. J. Pharmacol. 51:1974;391-397.
95. 1221,38α37. J. Pharmacol. Exp. Therap. 276:1996;56-64.
96. 9c-fos. Soc. Neurosci. Abstr. 20:1994;1676.
97. 9. Life Sci. 19:1976;347-356.
98. 933. J. Pharmacol. Exper. Ther. 207:1978;140-150.
99. 9. Clin. Exp. Pharmacol. Physiol. 6:1979;541-548.
100. 12. Neuroendocrinology. 61:1995;714-721.
101. Rodríguez de Fonseca F., Cebeira M., Fernández-Ruiz J. J., Navarro M., Ramos J. A. Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons. Neuroscience. 43:1991;713-723.
102. 9. Endocrinology. 109:1981;876-880.
103. Asch R. H., Smith C. G., Siler-Kohdr T. M., Pauerstein C. Acute decreases in serum prolactin concentrations caused by delta-9-tetrahydrocannabinol in nonhuman primates. Fertil. Steril. 32:1979;571-574.
104. 9. Endocrinology. 103:1978;452-458.
105. Rettori V., Wenger T., Snyder G., Dalterio S., McCann S. M. Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat. Neuroendocrinology. 47:1988;498-503.
106. Tyrey L., Hughes C. L. Jr. Inhibition of suckling-induced prolactin secretion by delta-9-tetrahydrocannabinol. Agurell S., Dewey W. L., Wilette R. E. The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects. 1984;487-495 Academic Press, San Diego.
107. 9. Neuroendocrinology. 58:1993;280-286.
108. 9. Endocrinology. 63:1974;415.
109. Lemberger L., Crabtree R., Rowe H., Clemens Y. Tetrahydrocannabinol and serum prolactin levels in man. Life Sci. 16:1975;1339-1343.
110. Zuardi A. W., Guimaraes F. S., Moreira A. C. Effects of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers. Braz. J. Med. Biol. Res. 26:1993;213-217.
111. Herkenham M., Lynn A. B., Little M. D., Johnson M. R., Melvin L. S., de Costa B. R., Rice K. C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA. 87:1990;1932-1936.
112. Mailleux P., Vanderhaeghen J. J. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 48:1992;655-668.
113. Lynn A. B., Herkenham M. Localization of cannabinoid receptors and nonsaturable high density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor mediated immune modulation by cannabinoids. J. Pharmacol. Exp. Ther. 268:1994;1612-1623.
114. 9. Pharmacol. Biochem. Behav. 40:1991;603-608.
115. Fernández-Ruiz J. J., Rodríguez de Fonseca F., Navarro M., Ramos J. A. Maternal cannabinoid exposure and brain development: Changes in the ontogeny of dopaminergic neurons. Murphy L. L., Bartke A. Marihuana/Cannabinoids: Neurobiology and Neurophysiology. 1992;119-164 CRC Press, Boca Raton.
116. 9. Neuroendocrinol. Lett. 16:1994;305-314.
117. Mailleux P., Vanderhaeghen J. J. Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: An in situ hybridization study. J. Neurochem. 61:1993;1705-1712.
118. Ovadia H., Wohlman A., Mechoulam R., Weidenfeld J. Characterization of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology. 34:1995;175-180.
119. 3. J. Pharmacol. Exp. Ther. 263:1992;1383-1390.
120. Clemens J. A., Sawyer B. D., Cerimele B. Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology. 100:1977;692-698.
121. Negro-Vilar A., Ojeda S. R., Advis J. P., McCann S. M. Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats. Endocrinology. 105:1979;86-91.
122. Tyrey L. Reversal of the delta-9-tetrahydrocannabinol inhibitory effect on prolactin secretion by rostral deafferentation of the medial basal hypothalamus. Neuroendocrinology. 44:1986;204-210.
123. Rinaldi-Carmona M., Barth E., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrié P., Brelière J. C., Le Fur G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-244.
124. Dalterio S. L., Michael S. D., Macmillan B. T., Bartke A. Differential effects of cannabinoid exposure and stress on plasma prolactin, growth hormone and corticosterone levels in male mice. Life Sci. 28:1981;761-766.
125. Müller E. E. Role of neurotransmitters and neuromodulators in the control of anterior pituitary hormone secretion. DeGroot L. J. Endocrinology. 1995;178-191 Saunders, Philadelphia.
126. Hillard C. J., Farber N. E., Hagen T., Bloom A. S. The effects of THC on serum thyrotropin levels in the rat. Pharmacol. Biochem. Behav. 20:1984;547-550.